Quaker Chemical (NYSE: KWR) EVP gains shares via RSUs and tax withholding

Rhea-AI Filing Summary

Quaker Chemical EVP Jeewat Bijlani increased his equity stake through vesting awards and related tax withholding. On March 15, 2026, he acquired 1,568 shares of common stock through the exercise and settlement of restricted stock units and dividend equivalent rights, all at a stated price of $0.00 per share.

He also received 2,195 new time-based restricted stock units as a compensation grant and 1,297 shares of common stock, both at no cash cost to him. To cover withholding taxes on vested performance and restricted stock awards, 923 shares of common stock were surrendered at $118.45 per share. After these transactions, he directly holds 6,748 shares of common stock, plus 61 shares held indirectly through a 401(k) plan.

Insider Trade Summary

1,568 shares exercised/converted

Mixed 12 txns

Insider Bijlani Jeewat

Role EVP, Glob. Spec. & CGO

Type	Security	Shares	Price	Value
Exercise	Restricted Stock Units	433	$0.00	--
Exercise	Restricted Stock Units	429	$0.00	--
Exercise	Restricted Stock Units	674	$0.00	--
Exercise	Dividend Equivalent Rights	32	$0.00	--
Grant/Award	Restricted Stock Units	2,195	$0.00	--
Grant/Award	Common Stock	1,297	$0.00	--
Exercise	Common Stock	433	$0.00	--
Exercise	Common Stock	429	$0.00	--
Exercise	Common Stock	674	$0.00	--
Exercise	Common Stock	32	$0.00	--
Tax Withholding	Common Stock	923	$118.45	$109K
holding	Common Stock	--	--	--

Holdings After Transaction: Restricted Stock Units — 433 shares (Direct); Dividend Equivalent Rights — 0 shares (Direct); Common Stock — 6,103 shares (Direct); Common Stock — 61 shares (Indirect, By 401(k))

Footnotes (1)

1. Shares earned upon vesting and settlement of Performance Stock Units (PSUs) awarded on March 15, 2023, upon certification of performance results by the Compensation and Human Resources Committee based on achievement of the adjusted return on invested capital (ROIC) metric, during the three year performance period. Restricted stock units (RSUs) convert into common stock on a one-for-one basis. Dividend equivalent rights (DERs) accrued on reporting person's RSUs granted on March 15, 2024 (two grants) and March 15, 2025. The rights accrued when and as dividends were paid on KWR common stock. This Form 4 reports the settlement of DERs in connection with the second installment of the 2024 RSU grants and the first installment of the 2025 RSU grant, each vesting on March 15, 2026. Each DER was the economic equivalent of one share of KWR common stock. Shares surrendered by reporting person to satisfy withholding tax obligation upon the full or partial vesting of restricted stock, PSUs, and RSUs previously granted under the Company's Long-Term Performance Incentive Plan. Information based on reporting person's Plan Statement as of December 31, 2025. On March 15, 2024, the reporting person was granted 1,298 time-based RSUs and 1,286 special time-based RSUs, with both vesting in three annual installments beginning on March 15, 2025. On March 15, 2025, the reporting person was granted 2,023 time-based RSUs, vesting in three equal installments beginning on March 15, 2026. Time-based RSUs granted under the Company's Long-Term Performance Incentive Plan, which will vest in three annual installments beginning on March 15, 2027. Each RSU represents a contingent right to receive one share of KWR common stock and DERs accrue with respect to these RSUs when and as dividends are paid on KWR common stock.

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Bijlani Jeewat

(Last) (First) (Middle)

901 E. HECTOR STREET

(Street)

CONSHOHOCKEN PA 19428-2380

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
QUAKER CHEMICAL CORP [ KWR ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	EVP, Glob. Spec. & CGO

3. Date of Earliest Transaction (Month/Day/Year)
03/15/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	03/15/2026		A		1,297(1)	A	$0	6,103	D
Common Stock	03/15/2026		M		433	A	(2)	6,536	D
Common Stock	03/15/2026		M		429	A	(2)	6,965	D
Common Stock	03/15/2026		M		674	A	(2)	7,639	D
Common Stock	03/15/2026		M		32	A	(3)	7,671	D
Common Stock	03/15/2026		F		923(4)	D	$118.45	6,748	D
Common Stock								61(5)	I	By 401(k)

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Restricted Stock Units	(2)	03/15/2026		M			433	(6)	(6)	Common Stock	433	$0	433	D
Restricted Stock Units	(2)	03/15/2026		M			429	(6)	(6)	Common Stock	429	$0	429	D
Restricted Stock Units	(2)	03/15/2026		M			674	(7)	(7)	Common Stock	674	$0	1,349	D
Dividend Equivalent Rights	(3)	03/15/2026		M			32	(3)	03/15/2026	Common Stock	32	(3)	0	D
Restricted Stock Units	(8)	03/15/2026		A		2,195		(8)	(8)	Common Stock	2,195	$0	2,195	D

Explanation of Responses:

1. Shares earned upon vesting and settlement of Performance Stock Units (PSUs) awarded on March 15, 2023, upon certification of performance results by the Compensation and Human Resources Committee based on achievement of the adjusted return on invested capital (ROIC) metric, during the three year performance period.

2. Restricted stock units (RSUs) convert into common stock on a one-for-one basis.

3. Dividend equivalent rights (DERs) accrued on reporting person's RSUs granted on March 15, 2024 (two grants) and March 15, 2025. The rights accrued when and as dividends were paid on KWR common stock. This Form 4 reports the settlement of DERs in connection with the second installment of the 2024 RSU grants and the first installment of the 2025 RSU grant, each vesting on March 15, 2026. Each DER was the economic equivalent of one share of KWR common stock.

4. Shares surrendered by reporting person to satisfy withholding tax obligation upon the full or partial vesting of restricted stock, PSUs, and RSUs previously granted under the Company's Long-Term Performance Incentive Plan.

5. Information based on reporting person's Plan Statement as of December 31, 2025.

6. On March 15, 2024, the reporting person was granted 1,298 time-based RSUs and 1,286 special time-based RSUs, with both vesting in three annual installments beginning on March 15, 2025.

7. On March 15, 2025, the reporting person was granted 2,023 time-based RSUs, vesting in three equal installments beginning on March 15, 2026.

8. Time-based RSUs granted under the Company's Long-Term Performance Incentive Plan, which will vest in three annual installments beginning on March 15, 2027. Each RSU represents a contingent right to receive one share of KWR common stock and DERs accrue with respect to these RSUs when and as dividends are paid on KWR common stock.

Remarks:

	Victoria K. Gehris, Attorney-in-Fact for Jeewat Bijlani	03/17/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What equity awards did Quaker Chemical (KWR) EVP Jeewat Bijlani receive?

Jeewat Bijlani received 2,195 new time-based restricted stock units and 1,297 shares of Quaker Chemical common stock at no cash cost, reflecting routine long-term incentive compensation under the company’s performance and time-based equity programs.

How many Quaker Chemical (KWR) shares did Jeewat Bijlani acquire through vesting?

Bijlani acquired 1,568 Quaker Chemical common shares through the exercise and settlement of restricted stock units and dividend equivalent rights, all at a stated price of $0.00 per share, as previously granted equity awards vested based on performance and time-based schedules.

Why did Jeewat Bijlani surrender Quaker Chemical (KWR) shares in this Form 4?

He surrendered 923 shares of Quaker Chemical common stock at $118.45 per share to satisfy withholding tax obligations triggered by the vesting of restricted stock, performance stock units, and restricted stock units granted under the company’s Long-Term Performance Incentive Plan.

What are Jeewat Bijlani’s Quaker Chemical (KWR) share holdings after these transactions?

Following the reported transactions, Bijlani directly holds 6,748 shares of Quaker Chemical common stock. He also has an indirect holding of 61 shares through a 401(k) plan, based on his plan statement as of December 31, 2025.

How were dividend equivalent rights used in Jeewat Bijlani’s Quaker Chemical (KWR) awards?

Dividend equivalent rights accrued on Bijlani’s restricted stock units granted in 2024 and 2025 and were settled into 32 shares of Quaker Chemical common stock when related RSU installments vested, with each right being economically equivalent to one share of common stock.

What performance metric affected Jeewat Bijlani’s Quaker Chemical (KWR) PSU vesting?

Performance stock units awarded on March 15, 2023 vested based on adjusted return on invested capital (ROIC) over a three-year performance period, with results certified by Quaker Chemical’s Compensation and Human Resources Committee before shares were delivered.